litlas
Log inCreate account

Tomoki Naoe

Active 1993–2024

80
Papers
24,608
Citations
69
h-index
80
i10-index

Citations

Citations per year for Tomoki Naoe1981: 1 citations1984: 1 citations1992: 2 citations1994: 1 citations1995: 1 citations1996: 2 citations1997: 11 citations1998: 19 citations1999: 42 citations2000: 39 citations2001: 62 citations2002: 109 citations2003: 108 citations2004: 72 citations2005: 85 citations2006: 76 citations2007: 100 citations2008: 139 citations2009: 174 citations2010: 237 citations2011: 253 citations2012: 229 citations2013: 178 citations2014: 189 citations2015: 152 citations2016: 161 citations2017: 185 citations2018: 191 citations2019: 884 citations2020: 906 citations2021: 780 citations2022: 626 citations2023: 414 citations2024: 569 citations2025: 203 citations2026: 4 citations1982–1983: no citations, so these years are not shown1985–1991: no citations, so these years are not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,547 citing papers, 24.8% of this breakdownChina: 1,135 citing papers, 11.1% of this breakdownGermany: 827 citing papers, 8.1% of this breakdownItaly: 550 citing papers, 5.3% of this breakdownUnited Kingdom: 536 citing papers, 5.2% of this breakdownFrance: 512 citing papers, 5% of this breakdownJapan: 509 citing papers, 5% of this breakdownNetherlands: 315 citing papers, 3.1% of this breakdownSpain: 304 citing papers, 3% of this breakdownCanada: 277 citing papers, 2.7% of this breakdownAustralia: 193 citing papers, 1.9% of this breakdownSwitzerland: 186 citing papers, 1.8% of this breakdown
0%24.8%Other 23%

Institutions

Fields

  • Medicine63.6%
  • Biochemistry, Genetics and Molecular Biology30.9%
  • Immunology and Microbiology2.5%
  • Agricultural and Biological Sciences0.6%
  • Computer Science0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.4%

Topics

  • Acute Myeloid Leukemia Research16.7%
  • Acute Lymphoblastic Leukemia research4.8%
  • Chronic Myeloid Leukemia Treatments4.5%
  • MicroRNA in disease regulation4.2%
  • Retinoids in leukemia and cellular processes4%
  • Hematopoietic Stem Cell Transplantation3.6%
  • Other62.2%

Coauthors

All papers

Open in search
  1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Authors: Hartmut Döhner, Elihu H. Estey, David Grimwade, Sergio Amadori, Frederick R. Appelbaum, Thomas Büchner, Hervé Dombret, Benjamin L. Ebert, Pierre Fenaux, Richard A. Larson, Ross L. Levine, Francesco Lo‐Coco, Tomoki Naoe, Dietger Niederwieser, Gert J. Ossenkoppele, Miguel Á. Sanz, Jorge Sierra, Martin S. Tallman, Hwei‐Fang Tien, Andrew H. Wei, Bob Löwenberg, Clara D. Bloomfield - Blood 2016 cited by 5,868

  2. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

    Authors: Hartmut Döhner, Elihu H. Estey, Sergio Amadori, Frederick R. Appelbaum, Thomas Büchner, Alan K. Burnett, Hervé Dombret, Pierre Fenaux, David Grimwade, Richard A. Larson, Francesco Lo‐Coco, Tomoki Naoe, Dietger Niederwieser, Gert J. Ossenkoppele, Miguel Á. Sanz, Jorge Sierra, Martin S. Tallman, Bob Löwenberg, Clara D. Bloomfield - Blood 2009 cited by 3,392

  3. Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

    Authors: Miguel Á. Sanz, Pierre Fenaux, Martin S. Tallman, Elihu H. Estey, Bob Löwenberg, Tomoki Naoe, Eva Lengfelder, Hartmut Döhner, Alan K. Burnett, Sai-Juan Chen, Vikram Mathews, Harry Iland, Eduardo Magalhães Rego, Hagop M. Kantarjian, Lionel Adès, Giuseppe Avvisati, Pau Montesinos, Uwe Platzbecker, Farhad Ravandi, Nigel H. Russell, Francesco Lo‐Coco - Blood 2019 cited by 655

  4. Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+ T Cells

    Authors: Keisuke Watanabe, Seitaro Terakura, Anton C. Martens, Tom van Meerten, Susumu Uchiyama, Misa Imai, Reona Sakemura, Tatsunori Goto, Ryo Hanajiri, Nobuhiko Imahashi, Kazuyuki Shimada, Akihiro Tomita, Hitoshi Kiyoi, Tetsuya Nishida, Tomoki Naoe, Makoto Murata - The Journal of Immunology 2014 cited by 285

  5. Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy

    Authors: Eunice S. Wang, Pau Montesinos, Mark D. Minden, Je‐Hwan Lee, Michael Heuser, Tomoki Naoe, Wen‐Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K. Altman, Violaine Havelange, Anne-Marie Watson, Carlo Gambacorti‐Passerini, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E. Hill, Stanley C. Gill, Elizabeth Rich, Ramón V. Tiu - Blood 2022 cited by 126

  6. A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations

    Authors: Takeshi Yamaura, Toshiyuki Nakatani, Ken Uda, Hayato Ogura, Wigyon Shin, Naoya Kurokawa, Koichi Saito, N. Fujikawa, Tomomi Date, Masaru Takasaki, Daisuke Terada, Atsushi Hirai, Akimi Akashi, Fangli Chen, Yoshiya Adachi, Yuichi Ishikawa, Fumihiko Hayakawa, Shinji Hagiwara, Tomoki Naoe, Hitoshi Kiyoi - Blood 2017 cited by 148

  7. Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

    Authors: Isao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, Hiroshi Fujiwara, Tetsuya Nishida, Yoshiki Akatsuka, Hiroaki Ikeda, Kazushi Tanimoto, Seitaro Terakura, Makoto Murata, Yoko Inaguma, Masahiro Masuya, Naoki Inoue, Tomohide Kidokoro, Sachiko Okamoto, Daisuke Tomura, Hideto Chono, Ikuei Nukaya, Junichi Mineno, Tomoki Naoe, Nobuhiko Emi, Masaki Yasukawa, Naoyuki Katayama, Hiroshi Shiku - Blood 2017 cited by 168

  8. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults

    Authors: Takahiko Yasuda, Shinobu Tsuzuki, Masahito Kawazu, Fumihiko Hayakawa, Shinya Kojima, Toshihide Ueno, Naoto Imoto, Shinji Kohsaka, Akiko Kunita, Koichiro Doi, Toru Sakura, Toshiaki Yujiri, Eisei Kondo, Katsumichi Fujimaki, Yasunori Ueda, Yasutaka Aoyama, Shigeki Ohtake, Junko Takita, Eirin Sai, Masafumi Taniwaki, Mineo Kurokawa, Shinichi Morishita, Masashi Fukayama, Hitoshi Kiyoi, Yasushi Miyazaki, Tomoki Naoe, Hiroyuki Mano - Nature Genetics 2016 cited by 271

  9. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Authors: Miguel Á. Sanz, David Grimwade, Martin S. Tallman, Bob Löwenberg, Pierre Fenaux, Elihu H. Estey, Tomoki Naoe, Eva Lengfelder, Thomas Büchner, Hartmut Döhner, Alan K. Burnett, Francesco Lo‐Coco - Blood 2008 cited by 957

  10. Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

    Authors: Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, Isamu Sugiura, Masashi Sawa, Nobuaki Dobashi, Hisayuki Yokoyama, Noriko Doki, Akihiro Tomita, Toru Kiguchi, Shiro Koh, Heiwa Kanamori, Noriyoshi Iriyama, Akio Kohno, Yukiyoshi Moriuchi, Noboru Asada, Daiki Hirano, Kazuto Togitani, Toru Sakura, Maki Hagihara, Tatsuki Tomikawa, Yasuhisa Yokoyama, Norio Asou, Shigeki Ohtake, Itaru Matsumura, Yasushi Miyazaki, Tomoki Naoe, Hitoshi Kiyoi - Blood Advances 2020 cited by 127

  11. Phase I study of OPB‐51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies

    Authors: Michinori Ogura, Toshiki Uchida, Yasuhito Terui, Fumihiko Hayakawa, Yukio Kobayashi, Masafumi Taniwaki, Yasushi Takamatsu, Tomoki Naoe, Kensei Tobinai, Wataru Munakata, Takeshi Yamauchi, Akiko Kageyama, Miyuki Yuasa, Masaaki Motoyama, Takeshi Tsunoda, Kiyohiko Hatake - Cancer Science 2015 cited by 102

  12. Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations

    Authors: Takahiko Yasuda, Masashi Sanada, Masahito Kawazu, Shinya Kojima, Shinobu Tsuzuki, Hiroo Ueno, Eisuke Iwamoto, Yuka Iijima‐Yamashita, Tomomi Yamada, Takashi Kanamori, Rieko Nishimura, Yachiyo Kuwatsuka, Satoru Takada, Masatsugu Tanaka, Shuichi Ota, Nobuaki Dobashi, Etsuko Yamazaki, Asao Hirose, Tohru Murayama, Masahiko Sumi, Shinya Sato, Naoyuki Tange, Yukinori Nakamura, Yuna Katsuoka, Emiko Sakaida, Toyotaka Kawamata, Hiroatsu Iida, Yuichi Shiraishi, Yasuhito Nannya, Seishi Ogawa, Masafumi Taniwaki, Norio Asou, Yoshihiro Hatta, Hitoshi Kiyoi, Itaru Matsumura, Keizo Horibe, Hiroyuki Mano, Tomoki Naoe, Yasushi Miyazaki, Fumihiko Hayakawa - Blood 2021 cited by 53

  13. EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases

    Authors: Hiroshi Kimura, Yoshinori Ito, Shinji Kawabe, Kensei Gotoh, Yoshiyuki Takahashi, Seiji Kojima, Tomoki Naoe, Shinichi Esaki, Atsushi Kikuta, Akihisa Sawada, Keisei Kawa, Koichi Ohshima, Shigeo Nakamura - Blood 2011 cited by 441

  14. Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance

    Authors: Junji Hiraga, Akihiro Tomita, Takumi Sugimoto, Kazuyuki Shimada, Masafumi Ito, Shigeo Nakamura, Hitoshi Kiyoi, Tomohiro Kinoshita, Tomoki Naoe - Blood 2009 cited by 258

  15. Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

    Authors: Takashi Oyama, Kazuhito Yamamoto, Naoko Asano, Aya Oshiro, Ritsuro Suzuki, Yoshitoyo Kagami, Yasuo Morishima, Kengo Takeuchi, Toshiyuki Izumo, Shigeo Mori, Koichi Ohshima, Junji Suzumiya, Naoya Nakamura, Masafumi Abe, Koichi Ichimura, Yumiko Sato, Tadashi Yoshino, Tomoki Naoe, Yoshie Shimoyama, Yoshikazu Kamiya, Tomohiro Kinoshita, Shigeo Nakamura - Clinical Cancer Research 2007 cited by 459

  16. Mechanism of constitutive activation of FLT3 with internal tandem duplication in the juxtamembrane domain

    Authors: Hitoshi Kiyoi, Ryuzo Ohno, Ryuzo Ueda, Hidehiko Saito, Tomoki Naoe - Oncogene 2002 cited by 283

  17. Microvesicle-mediated RNA Molecule Delivery System Using Monocytes/Macrophages

    Authors: Yukihiro Akao, Akio Iio, Tomohiro Itoh, Shunsuke Noguchi, Yuko Itoh, Yoshinori Ohtsuki, Tomoki Naoe - Molecular Therapy 2010 cited by 242

  18. Thrombosis from a Prothrombin Mutation Conveying Antithrombin Resistance

    Authors: Yuhri Miyawaki, Atsuo Suzuki, Junko Fujita, Asuka Maki, Eriko Okuyama, Moe Murata, Akira Takagi, Takashi Murate, Shinji Kunishima, Michio Sakai, Kohji Okamoto, Tadashi Matsushita, Tomoki Naoe, Hidehiko Saito, Tetsuhito Kojima - New England Journal of Medicine 2012 cited by 139

  19. Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan

    Authors: Takashi Tokunaga, Kazuyuki Shimada, Kazuhito Yamamoto, Dai Chihara, Takuji Ichihashi, Rika Oshima, Mitsune Tanimoto, Toshihiro Iwasaki, Atsushi Isoda, Akira Sakai, Hikaru Kobayashi, Kunio Kitamura, Kosei Matsue, Masafumi Taniwaki, Sadahiro Tamashima, Yoshio Saburi, Taro Masunari, Tomoki Naoe, Shigeo Nakamura, Tomohiro Kinoshita - Blood 2012 cited by 135

  20. Adipose Tissue-Derived Mesenchymal Stem Cells Facilitate Hematopoiesis in Vitro and in Vivo

    Authors: Norihiko Nakao, Takayuki Nakayama, Takashi Yahata, Yukari Muguruma, Shigeki Saito, Yasuhiko Miyata, Koji Yamamoto, Tomoki Naoe - American Journal Of Pathology 2010 cited by 133

  21. Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial

    Authors: Hartmut Döhner, Argiris Symeonidis, Dries Deeren, Judit Demeter, Miguel Á. Sanz, Αchilles Anagnostopoulos, Jordi Esteve, Walter Fiedler, Kimmo Porkka, Hee‐Je Kim, Je‐Hwan Lee, Kensuke Usuki, Stefano D’Ardìa, Chul Won Jung, Olga Salamero, Heinz‐August Horst, Christian Récher, Philippe Rousselot, Irwindeep Sandhu, Koen Theunissen, Felicitas Thol, Konstanze Döhner, Veronica Teleanu, Daniel J. DeAngelo, Tomoki Naoe, Mikkael A. Sekeres, Valérie Belsack, Miaomiao Ge, Tillmann Taube, Oliver G. Ottmann - HemaSphere 2021 cited by 29

  22. Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms

    Authors: Yasuhito Nannya, Magnus Tobiasson, Shinya Sato, Elsa Bernard, Shigeki Ohtake, June Takeda, Maria Creignou, Lanying Zhao, Manabu Kusakabe, Yuhei Shibata, Nobuhiko Nakamura, Mizuki Watanabe, Nobuhiro Hiramoto, Yusuke Shiozawa, Yuichi Shiraishi, Hiroko Tanaka, Kenichi Yoshida, Nobuyuki Kakiuchi, Hideki Makishima, Masahiro Nakagawa, Kensuke Usuki, Mitsumasa Watanabe, Kazunori Imada, Hiroshi Handa, Masataka Taguchi, Toru Kiguchi, Kazuma Ohyashiki, Takayuki Ishikawa, Akifumi Takaori‐Kondo, Hisashi Tsurumi, Senji Kasahara, Shigeru Chiba, Tomoki Naoe, Satoru Miyano, Elli Papaemanuil, Yasushi Miyazaki, Eva Hellström-Lindberg, Seishi Ogawa - Blood Advances 2023 cited by 26

  23. High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

    Authors: Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura, Hideki Akiyama, Noriko Usui, Fumiharu Yagasaki, Tohru Kobayashi, Yasunori Ueda, Makoto Takeuchi, Shuichi Miyawaki, Atsuo Maruta, Nobuhiko Emi, Yasushi Miyazaki, Shigeki Ohtake, Itsuro Jinnai, Keitaro Matsuo, Tomoki Naoe, Ryuzo Ohno - Journal of Clinical Oncology 2005 cited by 454

  24. Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study

    Authors: The Japan Adult Leukemia Study Group, Naoto Takahashi, Tetsuzo Tauchi, Kunio Kitamura, Koichi Miyamura, Yoshio Saburi, Yoshihiro Hatta, Yasuhiko Miyata, Shinichi Kobayashi, Kensuke Usuki, Itaru Matsumura, Yosuke Minami, Noriko Usui, Tetsuya Fukuda, Satoru Takada, Maho Ishikawa, Katsumichi Fujimaki, Hiroshi Gomyo, Osamu Sasaki, Kohshi Ohishi, Takaaki Miyake, Kiyotoshi Imai, Hitoshi Suzushima, Hideki Mitsui, Kazuto Togitani, Toru Kiguchi, Yoshiko Atsuta, Shigeki Ohtake, Kazunori Ohnishi, Yukio Kobayashi, Hitoshi Kiyoi, Yasushi Miyazaki, Tomoki Naoe - International Journal of Hematology 2017 cited by 94